|
|
Volumn 175, Issue 1, 2006, Pages 94-
|
|
Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: Results of a prospectively randomised trial of the german cooperative renal carcinoma chemoimmunotherapy group (DGCIN) - Commentary
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA2A INTERFERON;
FLUOROURACIL;
INTERLEUKIN 2;
CANCER ADJUVANT THERAPY;
CANCER IMMUNOTHERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
HIGH RISK POPULATION;
HUMAN;
KIDNEY CARCINOMA;
NEPHRECTOMY;
NOTE;
OUTPATIENT CARE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL;
|
|
EID: 29144533334
PISSN: 00225347
EISSN: None
Source Type: Journal
DOI: 10.1016/S0022-5347(05)00090-X Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|